Pharmaceutical Technology's In the Lab eNewsletter 12-02-2020

Assessing the integrity of filter membranes is critical for maintaining sterile filtration operations in laboratories.

Early detection and more sensitive methods of detecting adventitious agents are becoming increasingly critical in bioprocessing.

The announcement comes after the company saw growth and performance in Asia and decided to continue the expansion of biopharmaceutical manufacturing in the region.

The partners have established PathoQuest, Inc., a US subsidiary, and will construct an NGS-based testing lab at Charles River’s Wayne, PA, site.

The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry.

The expansion of the companies’ partnership will integrate lead optimization efforts to advance cancer immune therapy drug discovery.

Made up of Bio-Rad’s validated flow antibodies, the dyes offer maximal brightness and improved resolution of populations and low-density antigens for simple integration into multiplex panels.

The system gives R&D formulation chemists the ability to manufacture new formulations sooner, while allowing manufacturing teams to supply reliable batches of new drug products for commercial sale in an automated and compliant manner.

The new technology combines advanced high-performance liquid chromatography and ultra-high performance liquid chromatography capabilities to improve lab productivity.

Dolomite Microfluidics and MilliporeSigma have begun a collaboration to release off-the-shelf microfluidic device kits for the fabrication of PLGA particles.

The new powerful, precise, and compact instrument can be retrofitted for point-of-care clinical testing at urgent care facilities, hospitals, or physicians’ offices.